esonarimod has been researched along with Edema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kameo, K; Matsumoto, K; Takeshita, K; Tomisawa, K; Yasuda, Y | 1 |
| Fukushima, K; Hamada, Y; Higaki, M; Inoue, T; Takeshita, K | 1 |
2 other study(ies) available for esonarimod and Edema
| Article | Year |
|---|---|
Preparation and antirheumatic activity of optically active 2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298).
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Crystallography, X-Ray; Edema; Female; In Vitro Techniques; Interleukin-1; Lipopolysaccharides; Lymphocyte Activation; Mice; Mice, Inbred C3H; Optical Rotation; Phenylpropionates; Rats; Receptors, Interleukin-1; Spectrophotometry, Infrared; Stereoisomerism; T-Lymphocytes | 1996 |
KE-298 and its active metabolite KE-758 suppress nitric oxide production by murine macrophage cells and peritoneal cells from rats with adjuvant induced arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Cell Line, Transformed; Cyclooxygenase 2; DNA Primers; DNA-Binding Proteins; Edema; Enzyme Inhibitors; Female; Gene Expression; Injections, Intravenous; Interferon Regulatory Factor-1; Interferon-beta; Isoenzymes; Lipopolysaccharides; Macrophages, Peritoneal; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phenylbutyrates; Phenylpropionates; Phosphoproteins; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2001 |